Perioperative Hyperglycemia Increases Risk for Deep Wound Infection After Major Orthopedic
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Objective:

Methods:

Total hip and knee replacement surgery are one of the most frequent major surgeries
performed in USA. In 2002, the number of primary hip and knee arthroplasty was
119,000 and 381,000, respectively.(1) By year 2030 the number is projected to
increase to 572,000 and 3,481,000, respectively.(2)
Deep wound infection after major orthopedic surgery is one of the most serious
complications causing increase in morbidity and mortality and health care costs.(3)
Various risk factors for developing infection after hip and knee replacement surgery
were described including age, ASA PS status, obesity, patients’ comorbidities and
surgical technique factors.(4,5,6,7)
Perioperative hyperglycemia may increase the risk for infection after the surgery,(8)
but it is unknown if increases the risk after major orthopedic surgery.
We investigated whether high blood glucose increases a risk for periprosthetic joint
infection (PJI) after total hip and knee arthroplasty.

Demographic and surgical data in patients with and without infection
No Infection
N=17,770

Infection
N=190

p value

Male sex, n (%)

7,528 (42.36%)

97 (51.05%)

0.018*

Age, mean (SD)

64.02 (12.39)

63.61 (12.06)

0.570

BMI, mean (SD)

30.15 (6.54)

33.03 (9.66)

<0.001*

Bilateral , n (%)

2,669 (15.49%)

37 (20.33%)

0.080

9,636 (54.23%)
8,134 (45.77%)

63 (33.16%)
127 (66.84%)

<0.001*

Charlson Index, mean (SD)

2.32 (1.52)

2.53 (1.67)

0.060

ASA, mean (SD)

2.45 (0.59)

2.68 (0.55)

<0.001*

113.64 (40.07)

138.87 (65.80)

<0.001*

4.17 (2.24)

5.95 (6.51)

<0.01*

6,528 (36.74%)
2,170 (12.21%)
9,035 (50.84%)
37 (0.21%)

54 (28.42%)
38 (20.00%)
98 (51.58%)
0

0.008*

History of MI, n (%)

770 (4.33%)

15 (7.89%)

0.029*

History of Dementia, n (%)

26 (0.15%)

0

1.00

History of CAD, n (%)

180 (1.01%)

3 (1.58%)

0.447

History of CHF, n (%)

270 (1.52%)

10 (5.26%)

0.001*

History of tumor without mets, n (%)

54 (0.30%)

0

1.00

History of metastatic solid tumor, n (%)

165 (0.93%)

4 (2.11%)

0.105

Leukemia, n (%)

34 (0.19%)

0

1.00

2,133 (12.00%)

38 (20.00%)

0.002*

40 (0.23%)

0

1.00

1,773 (9.98%)

20 (10.53%)

0.807

Procedure, n (%)

THA
TKA

OR time, minutes, mean (SD)
Length of stay, days, mean (SD)
Disposition, n (%)

Home
Health care
Rehab
Other

DM, n (%)
Lymphoma, n (%)
Chronic Lung Disease, n (%)

531 (2.99%)

12 (6.32%)

0.016*

Mild liver disease, n (%)

19 (0.11%)

1 (0.53%)

0.192

Moderate to severe liver disease, n (%)

45 (0.25%)

1 (0.53%)

0.387

GI Ulcer, n (%)

103 (0.58%)

0

0.631

PVD, n (%)

108 (0.61%)

2 (1.05%)

0.325

Hemiplegia, n (%)

12 (0.07%)

0

1.00

Moderate to severe renal disease, n (%)

227 (1.28%)

8 (4.21%)

0.004*

OSA, n (%)

195 (1.10%)

1 (0.53%)

0.727

RA, n (%)
JRA, n (%)

383 (2.16%)
14 (0.08%)

8 (4.21%)
0

0.200

AMI, n (%)

53 (0.30%)

2 (1.05%)

0.115

Angina pectoris, n (%)

98 (0.55%)

2 (1.05%)

0.286

Acute renal failure, n (%)

77 (0.43%)

4 (2.11%)

0.011

DVT, n (%)

70 (0.39%)

3 (1.58%)

0.042*

PE, n (%)

182 (1.02%)

2 (1.05%)

0.722

AF, n (%)

834 (4.69%)

16 (8.42%)

0.024*

0.73 (0.66)

0.64 (0.72)

0.054

* - statistically significant, p <0.05

0.48 (1.03)

1.48 (2.21)

After obtaining IRB approval, we reviewed our computerized database for primary total hip and knee
arthroplasty from 2000 to 2008. Demographic information, past medical history of patients, perioperative
biochemistry and postoperative complications were reviewed.
Periprosthetic joint (deep wound) infection was defined as a deep infection below fascia, involvement of
muscle and/or bone. The diagnosis of deep periprosthetic infection was made if at least three of the
following five criteria were present: (1) abnormal serology (erythrocyte sedimentation rate 30 mm/hour; Creactive protein 1 mg/dL); (2) strong clinical and radiographic suspicion for periprosthetic infection such as
periosteal elevation, focal osteolysis, hot and swollen joint, draining sinus, (3) positive joint aspiration
culture; (4) evidence of purulence during the subsequent surgical intervention; and (5) a positive
intraoperative culture. The minimum follow-up was 12 months (mean, 43 months; range 12–76 months).
All patients have the same perioperative infection prophylaxis; 1 g intravenous cefazolin on induction and
continued for 24 hours post surgery (1 g vancomycin if allergic to cefazolin), laminar airflow operating room
environments, and helmet aspirator suits, as well as DVT prophylaxis with warfarin 5 to 10 mg, titrated to
achieve an International Normalized Ratio (INR) between 1.5 and 2.0.
Total hip arthroplasty was performed through a modified anterolateral approach using uncemented
components in all cases. Knee arthroplasty was performed under tourniquet using a medial parapatellar
arthrotomy approach using cemented fixation for all knees. No drains were used in any of the cases.
Neuraxial anesthesia was used for all surgeries unless contraindicated.
Continuous variables were tested using the t-test. Categorical variables were tested using Fischer’s exact
test. P values reported are two-sided.

Preoperative glucose and infection rate in diabetics and non diabetics.

non diabetics

200

<0.001*

Infection
N=190

p value

124.63 (27.03)

129.60 (31.26)

0.012*

A1C, %

6.70 (1.38)

7.72 (0.57)

0.099

Preop Creatinin, mg/dL

0.95 (0.46)

1.24 (1.76)

<0.001*

BUN, mg/dL

14.71 (5.75)

17.91 (9.88)

<0.001*

Creatinin rise, mg/dL

0.04 (0.25)

0.18 (0.77)

<0.001*

Postop Creatinin, mg/dL

0.93 (0.39)

1.16 (1.41)

<0.001*

Hb, mean, g/dL

11.03 (1.21)

10.62 (1.23)

<0.001*

Post op lowest Hb, g/dL

9.71 (1.42)

9.15 (1.46)

<0.001*

Hematocrit, %

32.84 (3.52)

31.77 (3.69)

<0.001*

Hb drop, g/dL

3.57 (1.34)

3.62 (1.56)

0.698

WBC, B/L

8.83 (2.49)

9.20 (2.70)

0.044*

PT, sec

16.69 (1.88)

17.05 (2.27)

0.009*

PTT, sec

31.14 (6.18)

32.84 (7.72)

<0.001*

INR

1.32 (0.20)

1.36 (0.24)

0.009*

Platelet count, B/L

218.34 (57.48)

220.56 (68.53)

0.598

Fibrinogen, mg/dL

376.98 (92.25)

435 (106.62)

0.013*

4.03 (0.55)

3.66 (0.71)

<0.001*

ALK phos, IU/L

75.15 (38.97)

106.20 (128.24)

<0.001*

ALT, IU/L

28.13 (42.02)

28.30 (17.31)

0.983

Amylase, U/L

69.93 (72.33)

117.92 (74.84)

0.354

AST, IU/L

32.42 (45.67)

37.53 (32.13)

0.476

Direct Bilirubin, mg/dL

0.36 (0.54)

0.35 (0.27)

0.895

Total Bilirubin, mg/dL

0.76 (0.86)

0.88 (0.55)

0.378

589.42 (698.15)

210.60 (141.05)

0.233

1.51 (8.57)

1.86 (5.00)

0.877

Cholesterol, mg/dL

172.92 (48.20)

161.75 (54.44)

0.224

HDL, mg/dL

41.45 (12.80)

38.31 (13.68)

0.379

LDL, mg/dL

87.51 (32.52)

86.13 (43.92)

0.880

Triglycerides, mg/dL

102.45 (70.11)

91.95 (34.68)

0.590

Lipase, U/L

34.61 (48.80)

75.40 (83.67)

0.114

Glucose, mg/dL

Albumin, g/dL

Troponin, ng/mL

175

180
160

No Infection
N=17,770

BNP, pg/mL

diabetics

145.79

140

Connective tissue disease, n (%)

Transfusion (auto) ,PRBC units, mean
(SD)
Transfusion (allo), PRBC units, mean (SD)

Metabolic factors in patients with infection. Data are mean (SD).

120
100.53
100

Mean blood glucose

96

Mean blood glucose

80
140.00

60
135.00

40
129.60

130.00

20
125.00

0
Peop Glucose, mg/dL

Infections per 10000

Results:
Data from 17960 patients were included in the study. The incidence of periprosthetic joint (deep wound)
infection was 1.06 % (190/17960 patients, 95% CI 0.91, 1.21).
Infected patients tended to be male (51 vs 42 %, P=0.018), had higher BMI (33 vs 30 kg/m2, P<0.001),
higher ASA PS (2.68 vs 2.45, P<0.001), had history of (h/o) MI (7.9 vs 4.3 %, P=0.029), h/o renal disease
(4.2 vs 1.9 %, P=0.004), and h/o DM (20 vs 12 %, P=0.002). Longer operative time, knee arthroplasty
compared with hip arthroplasty were also significantly higher (p<0.001). Diabetic patients had significantly
higher preoperative glucose (145 vs 100, P<0.001) and higher infection rate (1.75% vs 0.96%, P=0.002).
Mean perioperative blood glucose (130 vs 125 mg/dL, P=0.012) was significantly higher in infected
patients. Significant metabolic markers of PJI were: higher preoperative creatinin (1.24 vs 0.95 mg/dL,
P<0.001), higher postoperative rise in creatinin (0.18 vs 0.04 mg/dL, P<0.001), lower mean perioperative
albumin (3.7 vs 4.0 g/dL, P<0.001), lower mean Hb (10.6 vs 11.0 g/dL, P<0.001), higher mean INR (1.36
vs 1.32, P=0.009), and higher BUN (14.7 vs 17.9 mg/dL, P=0.001).
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Conclusion:
We confirmed the known risk factors for PJI after total hip and knee arthroplasty; male sex, BMI, ASA
PS, h/o MI, h/o renal disease, h/o DM, longer duration of surgery and knee arthroplasty. Higher mean
perioperative blood glucose is a significant risk factor for PJI after total hip and knee arthroplasty. Other
significant metabolic risk factors were higher preoperative and mean postoperative creatinin,
postoperative rise in creatinin, lower mean albumin and higher mean INR and BUN.
The importance of this study is that the prevalence of PJI is believed to be on the rise once again and the
diagnosis of PJI continues to be challenging. Knowing the risk factors associated with PJI could help
physicians to indentify patients who may need more aggressive prophylaxis and postoperative infection
surveillance.
A prospective, randomized, controlled trial is required to determine whether optimizing blood glucose
perioperatively would decrease the incidence of deep would infection in this clinical setting.

